• 育成賞を受賞しました!

    2024.10.18 | お知らせ
    先日開催されました、第93回日本呼吸器学会九州支部秋季学術講演会にて 「免疫化学療法後の増悪に対して...
  • Lorlatinib versus crizotinib in patients with advanced ALK-positive non-small cell lung cancer: 5-year outcomes from the phase III CROWN study

    2024.07.10 | 抄読会論文
    抄読会要旨 今村光佑...
  • eClinical Medicine. 2024 Mar 22:70:102536. doi:10.1016/j.eclinm.2024.102536Title : Clinical spectrum and evolution of immune-checkpoint inhibitors toxicities over a decade—a worldwide perspective

    2024.06.7 | 抄読会論文
    抄読会要旨 猪山慎治...
  • First-line nivolumab plus ipilimumab with or without chemotherapy for Japanese patients with non-small cell lung cancer: LIGHT-NING study Jpn J Clin Oncol. 2024 Apr 6;54(4):452-462.

    2024.05.16 | 抄読会論文
    抄読会要旨 猿渡 功一...
  • 5/11sat.16:30~医局説明会を開催します☆

    2024.03.29 | お知らせ
    医局説明会2024PDF   令和6年度医局説明会を5月11日土曜日16時30分から開催し...
  • 呼吸器内科塾2024 開催のお知らせ 参加は無料! 当日参加も可能

    2024.04.2 | お知らせ
    呼吸器内科塾 2024  ...
  • Interstitial pneumonia with autoimmune features and histologic usual interstitial pneumonia treated with anti-fibrotic versus immunosuppressive therapy

    2024.02.19 | 抄読会論文
    抄読会要旨 岡林比呂子...
  • Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer

    2023.11.1 | 抄読会論文
    抄読会要旨 今村光佑...
  • Tumor Treating Fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study

    2023.10.27 | 抄読会論文
    抄読会要旨 猪山慎治...
  • High yield of pleural cell-free DNA for diagnosis of oncogenic mutations in lung adenocarcinoma

    2023.10.12 | 抄読会論文
    抄読会要旨 木村俊貴...
Copyright© 2024 熊本大学大学院生命科学研究部 呼吸器内科学分野 All rights reserved.